Cargando…

Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

IMPORTANCE: Immune checkpoint inhibitors (ICIs) are increasingly used in patients with advanced hepatocellular carcinoma (HCC). However, data on ICI therapy in patients with advanced HCC and impaired liver function are scarce. OBJECTIVE: To conduct a systematic review and meta-analysis to determine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Enrui, Yeo, Yee Hui, Scheiner, Bernhard, Zhang, Yue, Hiraoka, Atsushi, Tantai, Xinxing, Fessas, Petros, de Castro, Tiago, D’Alessio, Antonio, Fulgenzi, Claudia Angela Maria, Xu, Shuo, Tsai, Hong-Ming, Kambhampati, Swetha, Wang, Wenjun, Keenan, Bridget P., Gao, Xu, Xing, Zixuan, Pinter, Matthias, Lin, Yih-Jyh, Guo, Zhanjun, Vogel, Arndt, Tanaka, Takaaki, Kuo, Hsin-Yu, Kelley, Robin K., Kudo, Masatoshi, Yang, Ju Dong, Pinato, David J., Ji, Fanpu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450588/ https://www.ncbi.nlm.nih.gov/pubmed/37615958 http://dx.doi.org/10.1001/jamaoncol.2023.3284

Ejemplares similares

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study
por: D’Alessio, Antonio, et al.
Publicado: (2022)

Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
por: Liu, Chen-Hua, et al.
Publicado: (2021)

Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
por: Miyata, Tatsunori, et al.
Publicado: (2021)

Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma
por: Pinato, David J., et al.
Publicado: (2023)

Introducing Edward N. Pugh, Jr.
por: Sparre Andersen, Olaf
Publicado: (2008)

Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report
por: Uchida, Satoshi, et al.
Publicado: (2022)

Prediction of Mortality after Emergent Transjugular Intrahepatic Portosystemic Shunt Placement: Use of APACHE II, Child-Pugh and MELD Scores in Asian Patients with Refractory Variceal Hemorrhage
por: Tzeng, Wen-Sheng, et al.
Publicado: (2009)

Lenvatinib in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver function
por: Huynh, Jasmine, et al.
Publicado: (2022)

Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma
por: Manfredi, Giulia Francesca, et al.
Publicado: (2023)

Child Pugh and ALBI grade: past, present or future?
por: Rimini, Margherita, et al.
Publicado: (2020)

Laparoscopic Cholecystectomy in Child-Pugh Class C Cirrhotic Patients
por: Currò, Giuseppe, et al.
Publicado: (2005)

Electrocardiographic characteristics of cirrhotic patients and their association with Child‐Pugh score
por: Jahangiri, Soodeh, et al.
Publicado: (2023)

Application of acoustic radiation force impulse elastography combined with serum markers in Child-Pugh grading
por: Wei, Linglin, et al.
Publicado: (2020)

A molecular and preclinical comparison of the PD-1–targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab
por: Fessas, Petros, et al.
Publicado: (2017)

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
por: Vithayathil, Mathew, et al.
Publicado: (2022)

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
por: Vithayathil, Mathew, et al.
Publicado: (2023)

Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma
por: Itoh, Shinji, et al.
Publicado: (2022)

Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma
por: Pinato, David J., et al.
Publicado: (2023)

Immune-based therapies for hepatocellular carcinoma
por: Pinato, David J., et al.
Publicado: (2020)

Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy
por: Hasan, Shaakir, et al.
Publicado: (2017)

Influences of Oral Administration of Probiotics on Posthepatectomy Recovery in Patients in Child-Pugh Grade
por: Huang, Hao, et al.
Publicado: (2022)

Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7
por: Jiang, Jian-Qiang, et al.
Publicado: (2023)

Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma
por: Cheon, Jaekyung, et al.
Publicado: (2023)

Determination of hepatic extraction fraction with gadoxetate low‐temporal resolution DCE‐MRI‐based deconvolution analysis: validation with ALBI score and Child‐Pugh class
por: Phonlakrai, Monchai, et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab
por: Wu, Yue Linda, et al.
Publicado: (2022)

Operative treatment of terrible triad of the elbow with a modified Pugh standard protocol: Retrospective analysis of a prospective cohort
por: Liu, Guanyi, et al.
Publicado: (2018)

Is Laparoscopy-assisted Radical Gastrectomy Safe in Patients with Child-Pugh Class A Cirrhosis?
por: Kang, Sin Jae, et al.
Publicado: (2013)

Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2014)

The Safety and Clinical Outcomes of Chemoembolization in Child-Pugh Class C Patients with Hepatocellular Carcinomas
por: Choi, Tae Won, et al.
Publicado: (2015)

Child-Pugh B or C Cirrhosis Increases the Risk for Bleeding Following Colonoscopic Polypectomy
por: Soh, Hosim, et al.
Publicado: (2020)

Multiphase CT-based prediction of Child-Pugh classification: a machine learning approach
por: Thüring, Johannes, et al.
Publicado: (2020)

Changes in Inflammatory Markers Predict the Prognosis of Resected Hepatocellular Carcinoma with Child–Pugh A
por: Zhou, Jing, et al.
Publicado: (2022)

Association of Thyroid Function and Severity of Illness in Liver Cirrhosis as Measured by Child-Pugh Score
por: Raj, Aswin, et al.
Publicado: (2023)

Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
por: Costa, Frederico, et al.
Publicado: (2023)

Clinical impact of carbon‐ion radiotherapy on hepatocellular carcinoma with Child‐Pugh B cirrhosis
por: Hiroshima, Yuichi, et al.
Publicado: (2023)

PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future Prospects
por: D’Alessio, Antonio, et al.
Publicado: (2021)

Preoperative Combined Prediction Models Have Superior Capability in Predicting Survival as the Child-Pugh Grade in Patients with HCC after Interventional Embolotherapy
por: Xu, Meng Qing, et al.
Publicado: (2020)

Dieulafoy’s lesion of the rectum: a case report and review of the literature
por: Wang, Mo, et al.
Publicado: (2017)

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis
por: FEDERICO, ALESSANDRO, et al.
Publicado: (2015)

Community-Metabolome Correlations of Gut Microbiota from Child-Turcotte-Pugh of A and B Patients
por: Wei, Xiao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jq717af3lq54v1jaqj0r3sgcuv